Lazard Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.8M Sell
390,065
-34,308
-8% -$2.71M 0.05% 278
2025
Q4
$34.8M Sell
424,373
-11,338
-3% -$883K 0.06% 241
2025
Q3
$32.7M Buy
435,711
+86,034
+25% +$6.42M 0.04% 241
2025
Q2
$25.9M Buy
349,677
+26,678
+8% +$1.86M 0.04% 334
2025
Q1
$26.1M Sell
322,999
-16,842
-5% -$1.45M 0.04% 296
2024
Q4
$26.6M Sell
339,841
-2,085
-0.6% -$177K 0.04% 288
2024
Q3
$32.1M Buy
341,926
+28,082
+9% +$2.36M 0.04% 266
2024
Q2
$24.5M Buy
313,844
+91,738
+41% +$7.48M 0.03% 335
2024
Q1
$20.2M Buy
222,106
+58,679
+36% +$4.88M 0.02% 383
2023
Q4
$12.6M Sell
163,427
-7,433
-4% -$521K 0.02% 499
2023
Q3
$11.6M Buy
170,860
+141,811
+488% +$10.3M 0.02% 522
2023
Q2
$2.36M Buy
29,049
+13,336
+85% +$1.06M ﹤0.01% 859
2023
Q1
$1.29M Buy
+15,713
New +$1.12M ﹤0.01% 979

Other funds holding GEHC

Lazard Asset Management's GEHC Position: Q1 2026 in Review

Lazard Asset Management reduced its GE HealthCare (GEHC) stake by 8.1% in Q1 2026, selling an estimated $2.71M and leaving 390,065 shares worth $27.8M. The position accounts for 0.05% of the portfolio, ranked #278.

Lazard Asset Management first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $34.8M in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Lazard Asset Management held 390,065 shares of GE HealthCare worth $27.8M as of Q1 2026.
  • Lazard Asset Management sold 34,308 GE HealthCare shares in Q1 2026, an estimated $2.71M.
  • GE HealthCare made up 0.05% of Lazard Asset Management's portfolio in Q1 2026, its #278 holding.
  • Lazard Asset Management first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Lazard Asset Management's GE HealthCare position peaked at $34.8M in Q4 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.